Kinase Inhibitor Discovery
with an untiring quest for future therapeutics

Carna announces a poster presentation on design of ongoing Phase 1b study for its non-covalent BTK inhibitor AS-1763 at American Society of Hematology Annual Meeting

Carna announces a poster presentation featuring preclinical characterization of its non-covalent BTK inhibitor AS-1763 at American Society of Hematology Annual Meeting

FY2023 Q3 Presentation

Consolidated Financial Results for the Third Quarter of the Year Ending December 31, 2023

Carna announces acceptance of two posters on AS-1763 for presentation at ASH Annual Meeting

Carna Announces Positive Results from the Phase 1 MAD study of Sofnobrutinib (AS-0871)

Carna Announces International Nonproprietary Names Selection for AS-0871 and AS-0141

Announcement of Clinical Trials.gov Registration for GS-9911 Phase 1 Study